12/7
07:33 am
ganx
Gain Therapeutics, Inc. (NASDAQ: GANX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
Gain Therapeutics, Inc. (NASDAQ: GANX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
12/7
07:33 am
ganx
Gain Therapeutics, Inc. (NASDAQ: GANX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
Gain Therapeutics, Inc. (NASDAQ: GANX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
11/25
08:04 am
ganx
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
10/9
08:33 am
ganx
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
10/1
08:01 am
ganx
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.